Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6151
Axcelis
ACLS
$4.01B
| $2K | ﹤0.01% |
291
-252
| -46% | -$3.07K |
|
6152
Alico
ALCO
$280M
| $2K | ﹤0.01% |
50
-24
| -32% | -$1.04K |
|
6153
Angi Inc
ANGI
$229M
| $2K | ﹤0.01% |
43
-955
| -96% | -$48.7K |
|
6154
AngioDynamics
ANGO
$611M
| $2K | ﹤0.01% |
132
-351
| -73% | -$5.3K |
|
6155
Arrow Financial
AROW
$659M
| $2K | ﹤0.01% |
75
-198
| -73% | -$4.2K |
|
6156
Anterix
ATEX
$1.81B
| $2K | ﹤0.01% |
68
-180
| -73% | -$5.89K |
|
|
AXDX
6157
DELISTED
Accelerate Diagnostics
AXDX
| $2K | ﹤0.01% |
11
-30
| -73% | -$6.49K |
|
6158
PUT
Braskem
BAK
$928M
| $2K | ﹤0.01% |
300
-500
| -63% | -$3.86K |
|
6159
Barrett Business Services
BBSI
$959M
| $2K | ﹤0.01% |
148
-396
| -73% | -$3.73K |
|
6160
Bassett Furniture
BSET
$164M
| $2K | ﹤0.01% |
57
-149
| -72% | -$4.79K |
|
6161
Sierra Bancorp
BSRR
$528M
| $2K | ﹤0.01% |
153
-72
| -32% | -$1.21K |
|
6162
CALL
Babcock & Wilcox
BW
$1.39B
| $2K | ﹤0.01% |
+15
| New | +$2.77K |
|
6163
CAE Inc. Common Shares
CAE
$8.3B
| $2K | ﹤0.01% |
220
| – | – |
|
|
CCRN
6164
DELISTED
Cross Country Healthcare
CCRN
| $2K | ﹤0.01% |
168
-448
| -73% | -$6.08K |
|
6165
Century Communities
CCS
$1.91B
| $2K | ﹤0.01% |
80
-2,311
| -97% | -$48.2K |
|
6166
Coherus Oncology
CHRS
$217M
| $2K | ﹤0.01% |
123
-329
| -73% | -$10K |
|
|
CIVI
6167
DELISTED
Civitas Resources
CIVI
| $2K | ﹤0.01% |
4
-79
| -95% | -$73.5K |
|
6168
Columbus McKinnon
CMCO
$553M
| $2K | ﹤0.01% |
105
-279
| -73% | -$5.84K |
|
6169
Central Pacific Financial
CPF
$1.02B
| $2K | ﹤0.01% |
120
-56,880
| -100% | -$1.25M |
|
6170
Crawford & Co Class B
CRD.B
$491M
| $2K | ﹤0.01% |
279
-740
| -73% | -$5.11K |
|
6171
Carriage Services
CSV
$641M
| $2K | ﹤0.01% |
85
-227
| -73% | -$5.2K |
|
6172
Commercial Vehicle Group
CVGI
$154M
| $2K | ﹤0.01% |
331
-243
| -42% | -$1.29K |
|
6173
PUT
Civeo
CVEO
$345M
| $2K | ﹤0.01% |
167
| – | – |
|
6174
Casella Waste Systems
CWST
$5.71B
| $2K | ﹤0.01% |
421
-337
| -44% | -$2.06K |
|
6175
Dime Commercial Bancshares
DCOM
$1.8B
| $2K | ﹤0.01% |
78
-148
| -65% | -$3.97K |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.